Higher Dosing of Rifamycins Does Not Increase Activity against Mycobacterium tuberculosis in the Hollow-Fiber Infection Model
ED Pieterman, S van den Berg… - Antimicrobial Agents …, 2021 - Am Soc Microbiol
Improvements in the translational value of preclinical models can allow more-successful and
more-focused research on shortening the duration of tuberculosis treatment. Although the …
more-focused research on shortening the duration of tuberculosis treatment. Although the …
[HTML][HTML] Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on …
A Younoussa, SN Samidine, AT Bergeman… - BMC Infectious …, 2023 - Springer
Leprosy is an ancient infectious disease with an annual global incidence of around 200,000
over the past decade. Since 2018, the World Health Organization (WHO) recommends …
over the past decade. Since 2018, the World Health Organization (WHO) recommends …